Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with > 18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO)
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Windyga, Jerzy
- Holme, Pal A.
- Hermans, C.
- Chatterjee, Nirjhar
- Jiang, Hongyu
- Cano-Garcia, Viridiana
- Escuriola, Carmen
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0006-4971, 1528-0020
- Tipo:
- Meeting Abstract
- Páginas:
- -
- Factor de Impacto:
- 5,416 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
BLOOD ELSEVIER
Citas Recibidas en Web of Science: 1
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Windyga,J,Holme,PA,Hermans,C,Cid,AR,Chatterjee,N,Jiang,H,Cano,V et al. Real-World Clinical Management of Patients with Hemophilia and Inhibitors: Effectiveness and Safety of aPCC in Patients with > 18 Months' Follow-up in the FEIBA Global Outcome Study (FEIBA GO). 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). 2019. Orlando-FL. RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS:ELSEVIER. 2019.
Portal de investigación